JD Health International Inc.
JDHIF
$6.15
-$0.34-5.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.94% | 12.91% | 6.83% | 3.13% | -1.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.94% | 12.91% | 6.83% | 3.13% | -1.73% |
| Cost of Revenue | 17.06% | 11.47% | 5.87% | 2.15% | -2.72% |
| Gross Profit | 25.39% | 17.88% | 10.20% | 6.62% | 1.83% |
| SG&A Expenses | 14.66% | 10.58% | 6.43% | 4.56% | 1.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.52% | 11.27% | 5.99% | 2.65% | -1.88% |
| Operating Income | 184.91% | 134.39% | 74.18% | 40.65% | 10.14% |
| Income Before Tax | 58.10% | 65.28% | 73.78% | 62.42% | 47.51% |
| Income Tax Expenses | -26.09% | -8.02% | 14.26% | 32.55% | 54.38% |
| Earnings from Continuing Operations | 80.18% | 84.24% | 88.91% | 69.91% | 45.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 195.94% | 778.11% | 555.05% | 231.83% | 153.29% |
| Net Income | 80.29% | 84.44% | 89.22% | 70.33% | 46.31% |
| EBIT | 184.91% | 134.39% | 74.18% | 40.65% | 10.14% |
| EBITDA | 154.81% | 109.29% | 57.31% | 32.97% | 9.86% |
| EPS Basic | 79.34% | 83.40% | 87.96% | 69.41% | 45.53% |
| Normalized Basic EPS | 57.39% | 64.48% | 73.05% | 61.90% | 47.26% |
| EPS Diluted | 77.27% | 83.10% | 90.05% | 71.87% | 48.33% |
| Normalized Diluted EPS | 57.40% | 65.18% | 74.50% | 63.25% | 48.28% |
| Average Basic Shares Outstanding | 0.62% | 0.61% | 0.61% | 0.63% | 0.65% |
| Average Diluted Shares Outstanding | 0.53% | 0.21% | -0.12% | 0.02% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |